Contact your healthcare provider immediately if you have concerns or experience serious side effects
Recent labs are required prior to taking most weight loss medications as part of our weight loss program in San Antonio, Texas
Pricing may depend on: Cost estimates will become clearer once approval and commercialization plans are finalized by Eli Lilly and regulatory bodies
The First Phase Key details and approval criteria for liraglutide (Saxenda) for weight management include a target patient age of 18 years and older with a body mass index (BMI) of 30 kg/m2 or greater, or a BMI of 27 kg/m2 or greater with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia
Patent term extensions beyond the current dates are unlikely
If your BMI falls below the threshold for compounded GLP-1, you may still be a candidate for our Microdosing program, a lower dose protocol built for patients seeking the metabolic, appetite, and longevity benefits of GLP-1 therapy at a gentler entry point